Phathom Pharmaceuticals Inc (PHAT)
17.25
-0.90
(-4.96%)
USD |
NASDAQ |
Oct 04, 16:00
17.26
0.00 (0.00%)
After-Hours: 20:00
Phathom Pharmaceuticals Shareholders Equity (Annual): -72.76M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -72.76M |
| December 31, 2022 | -74.81M |
| December 31, 2021 | 72.16M |
| Date | Value |
|---|---|
| December 31, 2020 | 194.27M |
| December 31, 2019 | 227.96M |
| December 31, 2018 | -1.286M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-74.81M
Minimum
2022
227.96M
Maximum
2019
69.36M
Average
72.16M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Fortress Biotech Inc | 22.54M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 39.70M |